Skip to main content

Table 3 Biomechanical testing

From: Growth factor release by vesicular phospholipid gels: in-vitro results and application for rotator cuff repair in a rat model

Group Mean load to failure [N] Deficit to mean contralateral side [N] Reduced load to failure to contralateral side = ratio [%] p (compared to ratio Placebo)
Contralateral 34.15 ± 9.1* - - -
Placebo 21.40 ± 10.3 −16.78 62.71 -
G-CSF Low 26.19 ± 7.8 −5.68 81.62 0.020*
G-CSF High 24.78 ± 6.5 −7.63 80.39 0.062
Group Mean stiffness [N/mm] Deficit to mean contralateral side [N] Reduced stiffness to contralateral side = ratio [%] p (compared to ratio Placebo)
Contralateral 34.08 * ± 5.5 - - -
Placebo 18.68 ± 10.4 −20.78 47.34 -
G-CSF Low 16.57 ± 6.1 −17.76 48.27 0.242
G-CSF High 22.04 ± 7.0 −6.43 77.41 0.078
  1. Load to failure (N) and Stiffness (N/mm) – mean and standard deviation (±) of absolute values and ratio to healthy contralateral side (%).
  2. *Intergroup comparison showed significant differences only in comparison to the healthy contralateral side in load to failure (Placebo .007; G-CSF low .021;G-CSF high .015) and stiffness (p < .01 for all groups). Treatment group comparisons showed non significant differences (p > .05).